Therapeutic misconception—a false belief that individuals will benefit from participating in research—can bias informed consent. Ethics consultants can help by engaging participants’ and researchers’ understandings of risks and benefits and by asking good questions about the influences of researchers’ enthusiasm.
AMA J Ethics. 2018;20(11):E1100-1106. doi:
10.1001/amajethics.2018.1100.
Jonathan Alhalel, Nicolás Francone, Sharon Post, Catherine A. O’Brian, PhD, and Melissa A. Simon, MD, MPH
Underrepresentation of individuals with limited English proficiency who speak Spanish is ongoing in phase 3 biomedical clinical trials and exacerbates health inequity.
AMA J Ethics. 2022;24(4):E319-325. doi:
10.1001/amajethics.2022.319.
Miranda B. Olson, MSc, Stacey Springs, PhD, and Jay Baruch, MD
Responsible arts in health research requires interrogating what counts as evidence, especially when the insistence on rigor risks oversimplifying and diminishing what’s ineffable about the arts.
AMA J Ethics. 2022;24(7):E617-621. doi:
10.1001/amajethics.2022.617.
Artist and researcher Dr Mark Gilbert joins Ethics Talk to discuss arts-based research: what it is, who it’s for, and why we should pay closer attention to it as a method of clinical inquiry.
Dr Roma Subramanian joins Ethics Talk to discuss her article, coauthored with Dr Matthew J. Brooks: “How a Medical Orchestra Cultivates Creativity, Joy, Empathy, and Connection.”